(19)
(11) EP 4 232 045 A1

(12)

(43) Date of publication:
30.08.2023 Bulletin 2023/35

(21) Application number: 21882127.0

(22) Date of filing: 22.10.2021
(51) International Patent Classification (IPC): 
A61K 31/575(2006.01)
A61P 1/16(2006.01)
A61P 3/10(2006.01)
A61K 9/48(2006.01)
 A61K 31/4375(2006.01)
A61P 3/06(2006.01)
A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/575; A61P 3/10; A61K 9/20; A61K 31/4375; A61K 9/48; A61P 3/06; A61P 1/16
 
C-Sets:
  1. A61K 31/4375, A61K 2300/00;
  2. A61K 31/575, A61K 2300/00;
(86) International application number:
PCT/CN2021/125490
(87) International publication number:
WO 2022/083713 (28.04.2022 Gazette 2022/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.10.2020 US 202063104754 P

(71) Applicant: Shenzhen Hightide Biopharmaceutical Ltd.
Shenzhen, Guangdong 518000 (CN)

(72) Inventor:
  • LIU, Liping
    Shenzhen, Guangdong 518000 (CN)

(74) Representative: Ter Meer Steinmeister & Partner 
Patentanwälte mbB Nymphenburger Straße 4
80335 München
80335 München (DE)

   


(54) COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING FATTY LIVER DISEASE, DIABETES AND HYPERLIPIDEMIA